After PEP binds to PD-L1 on the surface of cancer cells, it will guide PD-L1 into lysosomes, making PD-L1 degraded and unable to circulate again, thereby down-regulating the expression of PD-L1 and restoring the killing effect of T cells on TNBC tumor cells (95). The gene discussed is CD274; the disease is cancer.